{"nctId":"NCT03522441","briefTitle":"Bioequivalence Study of Clindamycin Gel 1% in Treatment of Acne Vulgaris","startDateStruct":{"date":"2018-04-27","type":"ACTUAL"},"conditions":["Acne Vulgaris"],"count":1125,"armGroups":[{"label":"Clindamycin 1% gel (Akorn Pharmaceuticals)","type":"EXPERIMENTAL","interventionNames":["Drug: Clindamycin 1% Gel"]},{"label":"Clindamycin 1% gel (Greenstone LLC)","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Clindamycin 1% Gel"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]}],"interventions":[{"name":"Clindamycin 1% Gel","otherNames":[]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"IInclusion Criteria:\n\n* Male or non-pregnant, non-lactating female, ≥12 and ≤40 years of age with a clinical diagnosis of acne vulgaris.\n* Have facial acne with: ≥20 facial inflammatory lesions (papules and pustules) and ≥25 non-inflammatory lesions (open and closed comedones), and ≤2 nodulocystic lesions (nodules and cysts) and have an IGA score of 2, 3 or 4.\n\nExclusion Criteria:\n\n* Subject has more than 2 facial nodular lesions; any nodules present will be documented but not included in the inflammatory lesion count for analysis.\n* Subject has active cystic acne.\n* Subject has acne conglobata.\n* Subjects with excessive facial hair such as beards, sideburns, moustaches, etc. that would interfere with the diagnosis or assessment of acne.","healthyVolunteers":false,"sex":"ALL","minimumAge":"12 Years","maximumAge":"40 Years","stdAges":["CHILD","ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Percent Change in the Number of Inflamed Lesions (Papules/Pustules)- Time Frame: Baseline to 12 Weeks","description":null,"paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-66.22","spread":"28.002"},{"groupId":"OG001","value":"-72","spread":"27.19"},{"groupId":"OG002","value":"-16.02","spread":"34.238"}]}]}]},{"type":"PRIMARY","title":"Percent Change in the Non-inflammatory (Open and Closed Comedones) Lesion Counts - Change in Baseline to 12 Week","description":null,"paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-50.45","spread":"29.934"},{"groupId":"OG001","value":"-57.42","spread":"25.709"},{"groupId":"OG002","value":"-46.07","spread":"29.922"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":450},"commonTop":[]}}}